International Clinical Trial: Examination of a supplement to manage mood and brain activity in women with premenstrual dysphoric disorder (extreme emotional, behavioral, and physical symptoms in the 1 to 2 weeks before a period)

Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ISRCTN88979481) titled 'Examination of a supplement to manage mood and brain activity in women with premenstrual dysphoric disorder (extreme emotional, behavioral, and physical symptoms in the 1 to 2 weeks before a period)' on Oct. 19.

Study Type: Interventional

Study Design: Allocation: Randomized controlled trial Masking: Blinded (masking used) Control: Placebo Assignment: Parallel Purpose: Treatment

Primary Sponsor: Queen Mary University of London

Condition: Premenstrual dysphoric disorder (PMDD) Mental and Behavioural Disorders

Intervention: One hundred women with PMDD will be randomly allocated to one of two parallel arms. Par...